UiPath: The Trading Cheat Sheet

June 2, 2026

UiPath: The Trading Cheat Sheet

ARR, guidance, and what really changes the PATH conversation from here


Sponsored

First a note from Banyan Hill Research

Dear Reader,

You don’t need millions. You don’t need insider access.

Just follow 3 simple steps and you could own a stake in one of the most disruptive companies in history – before the IPO.

Click here to see the steps + ticker.

Regards,

Addison Wiggin
Founder, Grey Swan Investment Fraternity


FEATURED

UiPath: The Trading Cheat Sheet

UiPath does something in Q1 that the market has been asking for, quietly, for a while: it posted GAAP operating profit. And the stock still acted like it did not know what to do with it.

That is the UiPath problem in 2026. The fundamentals are getting cleaner. The investor base still wants proof that growth can hold up while the company leans into margin discipline.


The Cheat Sheet

  • ARR: $1.901B, up 12% year over year in Q1 FY2027 (quarter ended April 30, 2026)
  • Revenue: $418M, up 17% year over year in Q1 FY2027
  • GAAP operating income: $28M in Q1 FY2027
  • Net new ARR: $49M in Q1; DBNRR: 109%
  • Q2 FY2027 guide: revenue $395M to $400M; ARR $1.929B to $1.934B
  • FY2027 guide (raised): revenue $1.776B to $1.781B; ARR $2.058B to $2.063B; non-GAAP operating income $430M
  • Buyback activity: 20M shares repurchased in Q1 at $11.47 average; additional 2M through May 27 at $9.63 average

The part people skip is that UiPath is not being valued like a high-growth SaaS name anymore. It is being valued like a business that needs to prove two things at once: ARR durability and operating discipline. That is a tighter box to trade inside.

And yes, 109% dollar-based net retention is respectable. It is also not the 120% type of number that removes all doubt. So the stock stays jumpy.


What I Care About Next

  • ARR quality, not just ARR quantity. UiPath grew ARR 12% year over year to $1.901B. The next question is whether net new ARR can stay in the $45M to $60M range without discounting too aggressively, especially in large enterprise renewals.
  • Signal inside the guide. Q2 revenue guidance ($395M to $400M) implies a sequential step down from Q1’s $418M, which is normal seasonality, but traders tend to overreact to it anyway. The commentary around pipeline conversion matters more than the midpoint itself.
  • Margins becoming repeatable. A $28M GAAP operating profit in Q1 is a real milestone. The market will want to know if that is a one-quarter event or the start of a new baseline.
  • Agentic automation is either a tailwind or a buzzword. Management is framing UiPath as a leader in agentic automation. I am not allergic to the concept. I am allergic to vague promises. I want customer examples, cycle times, attach rates, and any hint that the platform is expanding inside existing accounts.
Sponsored


5 Little-Known Stocks Behind Today’s Defense Tech Shift

Behind the headlines, a major transformation is underway.

Modern warfare is being driven by AI, autonomous systems, and next generation technology. A handful of lesser known companies are helping power this shift.

This report uncovers five stocks quietly playing a critical role in the future of defense.

Learn More…


Slight tangent, but it matters: UiPath buying back stock at roughly $10 to $11 while also talking confidently about raised full-year guidance is a very different vibe than the caution we saw in parts of 2024 and 2025. It does not guarantee anything, but it does tighten the range of outcomes a little.


The Push and Pull in PATH

At first glance, the quarter was clean: ARR up 12%, revenue up 17%, guidance raised, and GAAP operating income positive. That is not nothing.

But the market is still stuck on a basic tension. UiPath is selling productivity and cost reduction, which should work in a slower economy. Yet it is also selling a platform that can get delayed by procurement friction, security reviews, and long implementation cycles when CIOs get cautious. Both can be true in the same quarter, which is why the stock tends to gap and then churn.

Here is where I am at: UiPath is slowly de-risking the financial model. The question is whether it can re-accelerate net new ARR without giving the margin gains back. If you are trading PATH, that is the fulcrum.


How I Would Frame Risk Levels

  • Green light: ARR continues trending toward the FY2027 year-end guide of $2.058B to $2.063B while management holds the $430M non-GAAP operating income outlook.
  • Yellow light: ARR hits the guide but net new ARR falls meaningfully, suggesting the company is leaning too hard on renewals and less on expansion.
  • Red light: ARR guide holds but operating leverage deteriorates, or the company starts defending growth with discounting that shows up as weaker retention later.

No clean ending here. The stock is still trying to decide whether UiPath is a durable compounder with improving profitability, or a good product living in a tough procurement world.

Worth a look if you like trading companies mid-transition. Start with ARR, then margins, then listen for how concrete the agentic automation demand sounds in real customer language.

More From Author

PANW: When Security Spending Becomes a Fixed Cost

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Categories